Between-group comparison of change in VAS score by disease duration.

Figshare2025-11-13 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Between-group_comparison_of_change_in_VAS_score_by_disease_duration_/30613196 数据链接链接失效反馈

官方服务：

资源简介：

Between-group comparison of change in VAS score by disease duration.

创建时间：

2025-11-13

“温阳化积法”辨治膜性肾病中医诊疗方案

中医肾病诊疗

临床疗效评估

2019-2022年温阳化积法与非自发缓解性膜性肾病疗效相关性的双向队列研究临床定位为多中心双向队列临床试验研究，产生温阳化积法治疗膜性肾病中医诊疗方案，目前尚属于本院科室优势病种使用标准，有待进一步优化使用，格式为PDF。在使用或对本课题科学数据再加工时，应在成果中标注数据来源，按照要求规范、准确的引用数据。其他：符合NMPA-CDE关于数据递交的相关要求。

国家人口健康科学数据中心70

Laboratory Values During and Post-Treatment.

临床疗效评估

生物标志物监测

Laboratory Values During and Post-Treatment.

Figshare2016-09-28 更新20

The feasibility and efficacy of neoadjuvant FOLFOXIRI followed by laparoscopic surgery for locally advaned rectal cancer: A phase II study

直肠癌新辅助化疗

临床疗效评估

Interventions: chemotherapy : FOLFOXIRI Primary outcome(s): Disease control rate: DCR Study Design: Single arm Non-randomized

NIAID Data Ecosystem10

Quality health indicators achieved over the first 12 months of observation, stratified by treatment allocation (N = 818).

临床疗效评估

医疗质量指标

Quality health indicators achieved over the first 12 months of observation, stratified by treatment allocation (N = 818).

Figshare2022-11-02 更新30

Randomized Clinical Trial on Ivermectin versus Thiabendazole for the Treatment of Strongyloidiasis

热带病药物

临床疗效评估

BackgroundStrongyloidiasis may cause a life-threatening disease in immunosuppressed patients. This can only be prevented by effective cure of chronic infections. Direct parasitologic exams are not sen

Figshare2016-01-18 更新10

Between-group comparison of change in VAS score by disease duration.

资源简介：

相关数据集